Li Li
Fortuna: 3 M $ al 31/05/2026
Fortuna: 3 M $ al 31/05/2026
Li Li is currently a Non-Executive Director at Shandong Boan Biotechnology Co., Ltd., a Director at Shandong Asj Biotechnology Co. Ltd., and a Director at Guangzhou Patronus Biotechnology Co. Ltd. Ms. Li's former position was as a Vice President at Luye Pharma Group Ltd. Ms. Li holds a Master's in Business Administration from China Europe International Business School and an undergraduate degree from Yantai University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 06/06/2025 | 3.500.000 ( 0,56 % ) | 3 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Director/Miembro de la Junta | 22/06/2020 |
Shandong Asj Biotechnology Co. Ltd. | Director/Miembro de la Junta | 01/02/2020 |
Guangzhou Patronus Biotechnology Co. Ltd. | Director/Miembro de la Junta | 01/11/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| LUYE PHARMA GROUP LTD. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Luye Pharma Group Ltd.
Luye Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Yantai University
Yantai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shandong Boan Biotechnology Co., Ltd.
Shandong Boan Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies for oncology, immunology, pain and endocrine diseases | Health Technology |
Shandong Asj Biotechnology Co. Ltd. | |
Guangzhou Patronus Biotechnology Co. Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.